Both in Pharmaceuticals
Connect Biopharma Holdings Limited vs InMed Pharmaceuticals
Over the past year CNTB returned −53.5% and INM returned +405.8%; their daily moves had a correlation of -0.02.
CNTB −53.5% INM +405.8%Growth of $1, one year, split-adjusted
| Metric | CNTB | INM |
|---|---|---|
| Price | $0.7805 | $8.75 |
| Market cap | $49.2M | $48.1M |
| Today | +0.83% | +420.83% |
| 1 month | −13.8% | +557.9% |
| 6 months | −68.5% | +1104.6% |
| Year to date | −72.3% | +725.5% |
| 1 year | −52.7% | +373.0% |
| Revenue growth (YoY) | +5666.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −624.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 16.6× | 24.8× |
| Net cash | $31.5M | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 137.4% | 338.3% |
| Short % of float | 18.7% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).